Combining Azacitidine (Vidaza®, Aza) and Donor Lymphocyte Infusions (DLI) as First Salvage Treatment in Patients (PTS) With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation (allo-SCT): Interim-Analysis From the Azarela
暂无分享,去创建一个
N. Kröger | T. Luft | I. Bruns | G. Kobbe | R. Fenk | R. Haas | A. Czibere | U. Platzbecker | C. Wolschke | T. Schroeder | L. Uharek | G. Bug | T. Schroeder | F. Zohren